Safety study of HW241045 in healthy adults
Part of Lungs & breathing clinical trials.
This trial tests the safety of a new drug called HW241045 in healthy volunteers. It helps doctors understand how the drug affects the body and if it causes any side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult between 18 and 55 years old.
- Females need to weigh at least 99 pounds (45 kg), and males at least 110 pounds (50 kg).
- Your body mass index (BMI) should be between 19 and 26.
- You cannot have any serious or chronic medical conditions (like heart, liver, or kidney disease).
- You cannot have had major surgery or injury in the last 3 months.
- You cannot have a history of drug or food allergies that could interfere with the study drug.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a first-in-human study of an investigational drug called HW252001. Healthy volunteers will receive a single dose to see how safe it is and how the body processes it.
This is an early-stage safety and tolerability study of a new drug called HW241045 in healthy volunteers. Researchers will test the drug at different doses to understand how the body processes it and what side effects it may cause.
This trial tests a new drug called HW243040 in healthy adults to see how safe it is. It helps researchers understand how the drug works in the body before testing it in patients with a condition.
This first-in-human trial tests a new medication called HSK47388 in healthy volunteers to see if it's safe and how the body processes it. If you're generally healthy, you may be able to help researchers understand this potential new treatment.
This early-stage study tests a new investigational drug called HW201877 in healthy volunteers. The goal is to see if the drug is safe and how the body processes it.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
Hear when a new IPF trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.